VI16832 is a broad-spectrum Type I kinase inhibitor used as an enrichment tool for comparative expression analysis of protein kinases in various cancer cell lines; it enables phosphoproteomics analysis leading to the identification of over 8,500 phosphopeptides, corresponding to nearly 1,700 distinct phosphopeptide species derived from 212 different members of the protein kinase superfamily, and significantly increases the number of identified phosphorylation sites on protein kinases across multiple cancer cell lines.